By Drug Target Review2025-04-17T09:00:40
A team of scientists from the University of Birmingham has discovered a powerful new treatment for psoriasis. The treatment uses a tripeptide that has shown steroid-level effectiveness in reducing symptoms, offering fresh hope for the long-term management of this chronic skin condition.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2026-03-27T13:06:00Z
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2023-03-02T13:57:58
Sponsored by Cell Signaling Technology
2023-09-27T13:56:39
Sponsored by Euretos
2023-04-12T15:28:08
Sponsored by nanoComposix
2023-02-07T15:25:20
Sponsored by Bio-Techne
Site powered by Webvision Cloud